These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 19120337

  • 1. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [Abstract] [Full Text] [Related]

  • 2. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R.
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [Abstract] [Full Text] [Related]

  • 3. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM, Knol MJ, Ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
    [Abstract] [Full Text] [Related]

  • 4. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A, Barzilai A, Heyman R, Baum S, Amichai B, Solomon M, Shpiro D, Trau H.
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [Abstract] [Full Text] [Related]

  • 5. Low bone mineral density in adult patients with moderate to severe atopic dermatitis.
    Haeck IM, Hamdy NA, Timmer-de Mik L, Lentjes EG, Verhaar HJ, Knol MJ, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Br J Dermatol; 2009 Dec; 161(6):1248-54. PubMed ID: 19673879
    [Abstract] [Full Text] [Related]

  • 6. Severe atopic dermatitis treated with everolimus.
    Van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA.
    J Dermatolog Treat; 2009 Dec; 20(6):365-7. PubMed ID: 19954394
    [Abstract] [Full Text] [Related]

  • 7. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
    Ezzat MH, Sallam MA, Shaheen KY.
    Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
    [Abstract] [Full Text] [Related]

  • 8. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 9. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 10. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
    Hon KL, Lam MC, Leung TF, Kam WY, Lee KC, Li MC, Fok TF, Ng PC.
    Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
    [Abstract] [Full Text] [Related]

  • 11. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
    Gerdes S, Kurrat W, Mrowietz U.
    Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
    [Abstract] [Full Text] [Related]

  • 12. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW, Sohn MH, Kim ES, Kim KW, Kim KE.
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [Abstract] [Full Text] [Related]

  • 13. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate sodium for immunosuppressive treatment in uveitis.
    Deuter CM, Doycheva D, Stuebiger N, Zierhut M.
    Ocul Immunol Inflamm; 2009 Aug; 17(6):415-9. PubMed ID: 20001262
    [Abstract] [Full Text] [Related]

  • 15. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
    Kou K, Aihara M, Matsunaga T, Chen H, Taguri M, Morita S, Fujita H, Yamaguchi Y, Kambara T, Ikezawa Z.
    Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
    [Abstract] [Full Text] [Related]

  • 16. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K, Schwartz I, Itschert G, Dieck AT.
    Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150
    [Abstract] [Full Text] [Related]

  • 17. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.
    Angelova-Fischer I, Bauer A, Hipler UC, Petrov I, Kazandjieva J, Bruckner T, Diepgen T, Tsankov N, Williams M, Fischer TW, Elsner P, Fluhr JW.
    Br J Dermatol; 2005 Oct; 153(4):767-73. PubMed ID: 16181458
    [Abstract] [Full Text] [Related]

  • 18. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
    Kwakkel-van Erp JM, Haeck IM, Paantjens AW, van de Graaf EA, van Ginkel WG, Knol MJ, de Bruin-Weller MS, Lammers JW, Knol EF, Bruijnzeel-Koomen C, Otten HG.
    J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
    [No Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J, Graham-Brown RA, Marks R, Camp RD, English JS, Freeman K, Holden CA, Rogers SC, Oliwiecki S, Friedmann PS, Lewis-Jones MS, Archer CB, Adriaans B, Douglas WS, Allen BR.
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [Abstract] [Full Text] [Related]

  • 20. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.